Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2007-5-11
pubmed:abstractText
Published studies of the prognostic value of left ventricular (LV) hypertrophy and LV geometric pattern in African-Americans were based on referred or hospitalized patients with hypertension or coronary heart disease. All-cause mortality rates and survival associated with LV geometric pattern were determined using echocardiography in a population-based sample of middle-aged and elderly African-American men and women. During the third (1993 to 1995) visit of the ARIC Study, echocardiography was performed at the Jackson, Mississippi, field center on the cohort of 2,445 African-Americans aged 49 to 75 years. M-Mode LV echocardiographic measurements were available for 1,722 persons. Mortality data were available through December 31, 2003. During the follow-up period (median 8.8 years, maximum 10.4), 160 deaths were identified. In men, multivariable-adjusted hazard ratios for all-cause mortality (compared with men with normal LV geometry) were 1.75 (95% confidence interval [CI] 0.71 to 4.33) in those with concentric LV hypertrophy, 0.38 (95% CI 0.08 to 1.88) in those with eccentric LV hypertrophy, and 0.79 (95% CI 0.41 to 1.54) in those with concentric remodeling. In women, multivariable-adjusted hazard ratios for all-cause mortality (compared with women with normal LV geometry) were 1.17 (95% CI 0.48 to 2.84) in those with concentric LV hypertrophy, 1.23 (95% CI 0.46 to 3.28) in those with eccentric LV hypertrophy, and 1.17 (95% CI 0.60 to 2.28) in those with concentric remodeling. In conclusion, in this population-based cohort of middle-aged and elderly African-Americans free of coronary heart disease, adjustment for baseline differences in cardiovascular disease risk factors and LV mass greatly attenuated the strength of the association between LV pattern and all-cause mortality risk in women. In men, an association between concentric LV hypertrophy and mortality risk remained.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-11231428, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-12848675, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-138494, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-15123573, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-1534335, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-15533730, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-15566908, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-15569859, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-1825164, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-2646917, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-2947749, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-4258936, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-709763, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-7884090, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-7884091, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-7897116, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-8267936, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-8606324, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-9472909, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-9485129, http://linkedlifedata.com/resource/pubmed/commentcorrection/17493471-9626845
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0002-9149
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1413-20
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:17493471-African Americans, pubmed-meshheading:17493471-Aged, pubmed-meshheading:17493471-Atherosclerosis, pubmed-meshheading:17493471-Case-Control Studies, pubmed-meshheading:17493471-Cause of Death, pubmed-meshheading:17493471-Coronary Disease, pubmed-meshheading:17493471-Echocardiography, pubmed-meshheading:17493471-Female, pubmed-meshheading:17493471-Follow-Up Studies, pubmed-meshheading:17493471-Humans, pubmed-meshheading:17493471-Hypertrophy, Left Ventricular, pubmed-meshheading:17493471-Male, pubmed-meshheading:17493471-Middle Aged, pubmed-meshheading:17493471-Mississippi, pubmed-meshheading:17493471-Prospective Studies, pubmed-meshheading:17493471-Regression Analysis, pubmed-meshheading:17493471-Research Design, pubmed-meshheading:17493471-Risk Factors, pubmed-meshheading:17493471-Sex Factors, pubmed-meshheading:17493471-Survival Analysis, pubmed-meshheading:17493471-Ventricular Remodeling
pubmed:year
2007
pubmed:articleTitle
Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).
pubmed:affiliation
University of Mississippi Medical Center, Jackson, MS, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural